The Effect of tau genotype on clinical features in FTDP-17

Parkinsonism & Related Disorders - Tập 11 - Trang 205-208 - 2005
Yasuhiko Baba1, Yoshio Tsuboi2, Matthew C. Baker3, Ryan J. Uitti1, Michael L. Hutton3, Dennis W. Dickson3, Matthew Farrer3, John D. Putzke1, Bryan K. Woodruff1, Bernardino Ghetti4, Jill R. Murrell4, Bradley F. Boeve5, Ronald C. Petersen5, Patrice Verpillat6, Alexis Brice6, Marie-Bernadette Delisle7, Oliver Rascol6,8, Kunimasa Arima9, Maurice W. Dysken10, Minoru Yasuda11
1Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
2Department of Neurology, Fukuoka University School of Medicine, Fukuoka, Japan
3Division of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
4Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
5Department of Neurology, Mayo Clinic, Rochester, MN, USA
6University Hospital Rangueil, Toulouse, France
7Department of Pathology, Toulouse, France
8Department of Clinical Pharmacology, University Hospital of Toulouse, Toulouse, France
9Department of Laboratory Medicine, National Center of Neurology and Psychiatry, Tokyo, Japan
10Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA.
11Department of Psychiatry and Neurology, Kobe Graduate School of Medicine, Hyogo, Japan

Tài liệu tham khảo

Foster, 1997, Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference, Ann Neurol, 41, 706, 10.1002/ana.410410606 Ghetti, 2003, Frontotemporal dementia and parkinsonism linked to chromosome 17 associated with tau gene mutations (FTDP-17T), 86 Reed, 2001, Phenotypic correlations in FTDP-17, Neurobiol Aging, 22, 89, 10.1016/S0197-4580(00)00202-5 Wszolek, 2003, Hereditary tauopathies and parkinsonism, Adv Neurol, 91, 153 Baker, 1999, Association of an extended haplotype in the tau gene with progressive supranuclear palsy, Hum Mol Genet, 8, 711, 10.1093/hmg/8.4.711 Houlden, 2001, Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype, Neurology, 56, 1702, 10.1212/WNL.56.12.1702 Maraganore, 2001, Case–control study of the extended tau gene haplotype in Parkinson's disease, Ann Neurol, 50, 658, 10.1002/ana.1228 Conrad, 1998, Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy, Neurosci Lett, 250, 135, 10.1016/S0304-3940(98)00417-0 Litvan, 2001, Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy, Neurology, 57, 138, 10.1212/WNL.57.1.138 Verpillat, 2002, Association between the extended tau haplotype and frontotemporal dementia, Arch Neurol, 59, 935, 10.1001/archneur.59.6.935 Hughes, 2003, Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Exp Neurol, 181, 12, 10.1016/S0014-4886(03)00024-4 Makrides, 2003, Microtubule-dependent oligomerization of tau: implications for physiological tau function and tauopathies, J Biol Chem, 278, 33298, 10.1074/jbc.M305207200 Walker, 2002, A family with a tau P301L mutation presenting with parkinsonism, Parkinsonism Relat Disord, 9, 121, 10.1016/S1353-8020(02)00003-2 de Silva, 2001, Strong association of a novel tau promoter haplotype in progressive supranuclear palsy, Neurosci Lett, 311, 145, 10.1016/S0304-3940(01)02109-7 Pastor, 2002, Further extension of the H1 haplotype associated with progressive supranuclear palsy, Mov Disord, 17, 550, 10.1002/mds.10076